Navigation Links
Alzheimer's Patients May Suffer 'Silent' Seizures

Mice with similar ailment experienced these subtle attacks, scientists say

WEDNESDAY, Sept. 5 (HealthDay News) -- Scientists say mice genetically altered to develop an Alzheimer's-like illness undergo "silent" brain seizures.

According to researchers at the Baylor College of Medicine, the seizures may explain why some people with advanced Alzheimer's have "spells" of increased confusion. The seizures observed in the mice would not be recognizable in the same way a convulsion or epileptic seizure can be noticed.

These subtle seizures may be linked to cellular changes caused by high brain levels of the Alzheimer's-linked amyloid beta protein.

Understanding the process behind the seizures may lead to treatments that can prevent or even reverse the progression of the disease, the researchers said in the September issue of Neuron.

The research team recorded electrical brain waves in the hippocampus, deep in the mice's brains. The hippocampus is a brain area associated with memory.

"This discovery has helped identify a new and potentially reversible neural mechanism that can explain the episodes of sudden severe confusion found in cases of advanced Alzheimer's disease," Dr. Jeffrey Noebels, director of the Bluebird Circle Developmental Neurogenetics Laboratory at Baylor College of Medicine, said in a prepared statement. "The cellular changes that give rise to this hyperexcitability appear slowly as the disease progresses, and, at a certain point, the brain networks actually become hyperexcitable, despite the loss of synapses and brain cells in this brain region. Further study may point to early treatment that might prevent these electrical brain spells, as well as slow down the progression of this debilitating disease."

Prior to this research, spells of increased confusion were thought to be a result of degenerating nerve cells. According to the researchers, the study indicated that they may result from excess amyloid beta and could signal future cognitive failure. Amyloid beta is a toxic protein fragment found in the brains of people with Alzheimer's disease and similar disorders.

Alzheimer's disease is the most common form of dementia. More than 5 million Americans are living with the disease, which is characterized by a progressive loss of memory and cognitive function. There is no known cure for the disease.

More information

For more about Alzheimer's disease, visit the Alzheimer's Association.

-- Madeline Vann

SOURCE: Baylor College of Medicine, news release, Sept. 5, 2007

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Testing genes for disease does not cause harm to children of people with Alzheimers
2. Age-Dependent Alterations Not Specific For Alzheimers Disease
3. Killing two birds (cholesterol and Alzheimers disease) with the same stone
4. Cancer Causing Protein May Heal Alzheimers
5. Exposure To High Aluminum Levels In Tap Water Lead To Rare Form Of Alzheimers
6. Sugar variant may make a world of difference to Alzheimers disease
7. Alzheimers Disease Enzyme may Interfere With Brain Function
8. Emotional Stress Could Be a Factor in Causing Alzheimers: Study
9. Alzheimers Incidence is Set to Quadruple by 2050
10. GAB2-A New Alzheimers Gene Identified
11. Reduced Oxygen to the Brain Increases Alzheimers Risk in Stroke Victims
Post Your Comments:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & ... (TGIG), has initiated cultivation and processing operations at its production facility, and opened ... , Puradigm is the manufacturer of a complete system of proactive air and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: